T78.2XXS Anaphylactic shock, unspecified, sequela

Name of the Condition

• Anaphylactic shock, unspecified, sequela (ICD-10 Code: T78.2XXS)

Summary

This code is used to document the residual effects of anaphylactic shock when the specific trigger was not identified or documented. Anaphylactic shock is a severe, life-threatening systemic reaction that requires immediate medical intervention. The sequela code applies when the condition persists or results in chronic complications after the acute episode.

Causes

Anaphylactic shock occurs when the immune system overreacts to a trigger, releasing histamine and other chemicals that cause widespread vasodilation and bronchoconstriction. Common triggers include medications, foods, insect stings, or other allergens, though the specific cause may be unknown in some cases. The sequela code is used when the effects of the initial reaction persist.

Risk Factors

• Previous anaphylactic reactions
• Known allergies or atopic conditions
• Exposure to potential allergens
• Delayed or inadequate epinephrine administration in prior reactions
• Underlying cardiovascular or respiratory conditions

Symptoms

• Persistent hypotension (low blood pressure)
• Chronic respiratory distress (wheezing, stridor, or cyanosis)
• Skin reactions (hives, angioedema, or flushing)
• Gastrointestinal symptoms (nausea, vomiting, or abdominal pain)
• Altered mental status (confusion, dizziness, or loss of consciousness)
• Long-term organ damage or functional impairment

Diagnosis

Diagnosis is based on clinical evaluation and patient history, focusing on residual effects of a prior anaphylactic event. Documentation must confirm the sequela is directly related to the initial shock episode. Tests may assess organ function or residual symptoms, but the code applies when the acute cause remains unspecified.

Treatment Options

• Management of chronic symptoms (e.g., bronchodilators, antihistamines)
• Supportive care for persistent respiratory or cardiovascular issues
• Rehabilitation for functional impairments
• Long-term monitoring for recurrence or complications

Prognosis and Follow-Up

Prognosis depends on the severity of the initial reaction and the extent of residual damage. Follow-up care focuses on symptom management, preventing future reactions, and addressing any chronic conditions. Regular monitoring is recommended to assess organ function and adjust treatment as needed.

Complications

• Chronic respiratory or cardiovascular dysfunction
• Persistent skin or gastrointestinal issues
• Increased risk of future anaphylactic reactions
• Psychological impact (e.g., anxiety related to triggers)

Lifestyle & Prevention

• Avoidance of known or suspected allergens
• Carrying emergency medications (e.g., epinephrine auto-injector)
• Wearing medical identification (e.g., bracelet)
• Educating others about the condition and emergency response
• Regular follow-up with an allergist or immunologist

When to Seek Professional Help

Seek immediate medical attention for symptoms of a new anaphylactic reaction, such as difficulty breathing, swelling, or dizziness. For sequela-related concerns, consult a healthcare provider if symptoms worsen, new complications arise, or preventive measures need adjustment.

Tips for Medical Coders

Use this code when documenting the residual effects of anaphylactic shock with an unspecified trigger. Ensure the medical record supports the sequela by linking it to a prior acute episode. Document any chronic symptoms or functional impairments to justify the code. Avoid using this code for acute reactions or when the trigger is known.